-
Product Insights
Gonorrhea Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Gonorrhea Clinical Trials Analysis Overview The Gonorrhea clinical trial report consists of 338 trials. The report provides an overview of the Gonorrhea clinical trials scenario. The report provides top-line data relating to the clinical trials on Gonorrhea. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type. The...
-
Sector Analysis
Human Papillomavirus (HPV) Vaccines Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Human Papillomavirus (HPV) Vaccines Marketed and Pipeline Drugs Report Overview HPV is a common virus that can affect different parts of the body. There are several types of HPV, including strains of HPV that cause warts on the hands, feet, and face, and about 30 HPV strains that can affect the genitals. Early detection and treatment of HPV can usually prevent the progression to cancer from happening. The virus remains relatively inactive in early infection but keeps the cell from...
-
Sector Analysis
Chlamydia Trachomatis Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Chlamydia Trachomatis Tests Market Report Overview The Chlamydia Trachomatis Tests market size was valued at $634.7 million in 2022. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia Trachomatis. In women, Chlamydia Trachomatis infections are often asymptomatic, however, if left untreated they can cause pelvic inflammatory disease (PID), which in turn can lead to additional complications such as infertility, ectopic pregnancy, and chronic pelvic pain. Chlamydia Trachomatis Tests Market Outlook 2022-2033 ($ Million) For more insights on...
-
Sector Analysis
Multi-Parameter Chlamydia Trachomatis and Neisseria Gonorrhoeae NAATs Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Multi Parameter Chlamydia Trachomatis and Neisseria Gonorrhoeae NAATs Market Report Overview The Multi-Parameter Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG) NAATs market size was valued at $1.06 billion in 2022. In women, Chlamydia Trachomatis infections are often asymptomatic, however, if left untreated they can cause pelvic inflammatory disease (PID), which in turn can lead to additional complications such as infertility, ectopic pregnancy, and chronic pelvic pain. Multi-Parameter CT/NG NAATs Market Outlook 2022-2033 ($ Billion) For more insights on the Multi-Parameter CT/NG...
-
Sector Analysis
Neisseria Gonorrhoeae Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Neisseria Gonorrhoeae Tests Market Report Overview The Neisseria Gonorrhoeae Tests market size was valued at $383.7 million in 2022. Neisseria Gonorrhoea is one of the most common sexually transmitted diseases (STD) worldwide, caused by the bacteria Neisseria gonorrhoea. N. gonorrhoea infections are more common in young adults. Other groups at higher risk of contracting gonorrhoea include individuals with multiple sexual partners, individuals with another STD, men having sex with men (MSM), and sex workers. Increases in the incidence of Neisseria...
-
Sector Analysis
Mpox (Monkeypox) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Mpox Marketed and Pipeline Drugs Report Overview Mpox (monkeypox) is an infectious disease caused by the monkeypox virus, an enveloped double-stranded DNA virus of the Orthopoxvirus genus in the Poxviridae family, which includes variola, cowpox, vaccinia, and other viruses. The two genetic clades of the virus are (Central Africa) clades I and (West Africa) Clade II. The current global outbreak (2022–23) is caused by Clade IIb, a subtype of the less severe West African clade. Poxviruses are brick-shaped, surrounded by a...
-
Sector Analysis
Respiratory Syncytial Virus (RSV) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
RSV Marketed and Pipeline Drugs Report Overview The respiratory syncytial virus was discovered in 1956, first as an isolate from a laboratory chimpanzee displaying symptoms of the common cold and later from infants suffering from respiratory disease. The most common clinical scenario for RSV is an upper respiratory tract infection that is typically mild and self-limiting. However, RSV is the leading cause of lower respiratory tract infections (LRTIs) in infants, with a peak age of hospitalization occurring at ages two...
-
Sector Analysis
Seasonal Influenza Prophylactics Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Seasonal Influenza Prophylactics Marketed and Pipeline Drugs Report Overview Influenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses designated as influenza types A, B, and C. These three types are members of the Orthomyxoviridae family and are structurally related. The Seasonal Influenza Prophylactics marketed, and pipeline drugs market research report includes an assessment of the disease epidemiology, leading marketed products with sales forecast, pricing and reimbursement, late-to-mid-stage pipeline products...
-
Product Insights
Kaposi Sarcoma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Kaposi Sarcoma Clinical Trials Market Report Overview The Kaposi Sarcoma Clinical Trial provides an overview of Kaposi Sarcoma Clinical trials scenario. The report provides top line data relating to the clinical trials on Kaposi Sarcoma. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.
-
Product Insights
Cellulitis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Cellulitis Clinical Trials Market Overview The Cellulitis Clinical Trial provides an overview of Cellulitis Clinical trials scenario. The report provides top line data relating to the clinical trials on Lupus Nephritis. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.